Zack's likes Rosetta Genomics


Zacks Small Cap Research initiates coverage on Rosetta Genomics (ROSG) with an Outperform rating.

Analysts like the company's microRNA platform and establish a price target of $10.

Shares currently exchange hands at $5.30.

From other sites
Comments (2)
  • vladsaar
    , contributor
    Comments (6) | Send Message
     
    #ROSG agrees w/ @Carl_C_Icahn & think that gene expression profiling & "Genetics.. going to be the major change..in the world..& in science"
    6 Mar 2014, 11:15 AM Reply Like
  • Jonathan Bluhm
    , contributor
    Comments (393) | Send Message
     
    Great news, I called on this stock to outperform during 2014 in my December article:
    http://seekingalpha.co...
    6 Mar 2014, 11:23 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs